Entity Details

Primary name ADA2
Entity type gene
Source Source Link

Details

PrimaryID51816
RefseqGeneNG_033943
SymbolADA2
Nameadenosine deaminase 2
Chromosome22
Location22q11.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate2000-09-07
ModificationDate2021-06-11

Ontological Relatives

UniProt IDsADA2_HUMAN

GO terms

Show/Hide Table
GOName
GO:0004000 adenosine deaminase activity
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0006154 adenosine catabolic process
GO:0007275 multicellular organism development
GO:0008083 growth factor activity
GO:0008201 heparin binding
GO:0008270 zinc ion binding
GO:0031685 adenosine receptor binding
GO:0035578 azurophil granule lumen
GO:0042803 protein homodimerization activity
GO:0043312 neutrophil degranulation
GO:0043394 proteoglycan binding
GO:0044267 cellular protein metabolic process
GO:0046103 inosine biosynthetic process

Diseases

Show/Hide Table
Disease IDSourceNameDescription
182410 OMIMSneddon syndrome (SNDNS)An autosomal recessive, systemic non-inflammatory thrombotic vasculopathy characterized by the association of livedo racemosa, and in some cases livedo reticularis, with cerebrovascular disease. Livedo racemosa is a persistent net-like violaceous-cyanotic, mottled discoloration of the skin affecting the legs, the arms, the buttocks and the trunk; livedo reticularis is limited to the extremities and is visible only in the cold. Cerebrovascular features include recurrent transient ischemic attacks, infarcts, and rarely spinal strokes or intracranial or subarachnoid hemorrhages. Headache and vertigo may precede the onset of livedo racemosa and cerebrovascular manifestations by several years. Rare neurologic symptoms include seizures, chorea, or myelopathies. The disease is caused by variants affecting the gene represented in this entry.
615688 OMIMVasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome (VAIHS)An autosomal recessive, systemic necrotizing vasculitis that affects medium and small arteries. The ensuing tissue ischemia can affect any organ, including the skin, musculoskeletal system, kidneys, gastrointestinal tract, and the cardiovascular and nervous systems. Organ involvement and disease severity are highly variable. Clinical features include recurrent ischemic stroke affecting the small vessels of the brain and resulting in neurologic dysfunction, recurrent fever, myalgias, livedoid rash, gastrointestinal pain and hepatosplenomegaly. The disease is caused by variants affecting the gene represented in this entry.

Interactions

2 interactions

InteractorPartnerSourcesPublicationsLink
ADA2SRRM2BioGRID16159877 details
ADA2KIF23BioGRID31586073 details